Home » Topics » Disease categories and therapies » Urology

Urology
RSS

N-Acetylcysteine to be evaluated in clinical study for the treatment of rhabdomyolysis

Jan. 8, 2007

Ozarelix cleared for phase IIb study in BPH

Jan. 5, 2007

Trial finds hMaxi-K gene transfer safe in erectile dysfunction patients

Jan. 5, 2007

Thalidomide to be evaluated for the treatment of MIA syndrome in dialysis patients / News in Context

Jan. 4, 2007

Japanese approval sought for Fosrenol in hyperphosphatemia

Dec. 27, 2006

NDA submission for sevelamer carbonate for patients on dialysis

Dec. 27, 2006

Ardana announces preliminary results in a phase II study in benign prostatic hyperplasia

Dec. 22, 2006

Orphan Therapeutics plans rolling NDA for Lucassin

Dec. 20, 2006

Enrollment completed in phase IIb study of elocalcitol in BPH

Dec. 20, 2006

Roscovitine shows promise in preclinical models of polycystic kidney disease

Dec. 19, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Breakthrough as GSK’s bepirovirsen clears 19% of chronic hep B infections
BioWorld
GSK plc has announced a breakthrough in the treatment of chronic hepatitis B, reporting a functional cure rate of 19% across two phase III trials of its antisense...
BMS’ mezigdomide doubles PFS in multiple myeloma
BioWorld
Bristol Myers Squibb Co. disclosed in March 2026 that the phase III portion of the seamless phase II/III Successor-2 study testing mezigdomide in combination with...